With a unique business model rooted in innovation-led drug development services, the company is betting big on global ...

According to Renaissance Capital, a leading provider of pre-IPO research and IPO-focused ETFs, there have been 100 IPOs ...

Welcome to Ask the analyst, where I put questions from Morningstar readers (and myself) to members of our equity research team. If you have a question about an ASX company or industry that we cover, ...

CoreWeave was founded as Atlantic Crypto, an Ethereum miner, but pivoted its business model in the crypto winter of 2018-2019 ...

Grayscale announced it filed a confidential S-1 form with the intention to perform an IPO. Following an approval from the US ...

Comparative assessments and other editorial opinions are those of U.S. News and have not been previously reviewed, approved ...

Circle's (CRCL) post–initial public offering (IPO) rally is facing skepticism from Wall Street. Yahoo Finance Senior Business ...

THE listing by Japanese telecom giant’s NTT data centre real estate investment trust (Reit) is a welcome fillip for the local ...

Total fundraising this year is projected to nearly double 2024 levels. In a recent report, Savills said the Hong Kong IPO market has witnessed a robust resurgence in early 2025, driven by high profile ...

Summary. Apogee Therapeutics, Inc. has filed proposed terms for a $250 million IPO. The firm is developing drug treatment candidates for atopic dermatitis, COPD and asthma.

Panera Bread has been seeing an increase in visitors, which bodes well for a possible IPO, says analytics company Placer.ai Last Updated: April 8, 2024 at 8:54 a.m. ET First Published: April 5 ...

The stock rout will make it difficult for new issuers to go public, a disappointing development for a venture market in dire need of liquidity. “It’s a monumental challenge to price an IPO in ...